Notice: Constant DATE_RFC7231 already defined in /srv/www/public/bpb/bpb/stg/includes/bootstrap.inc on line 258
The Base Pair Advantage | stg.bpb.bpb.cgstack.com

The Base Pair Advantage

Multiplex Technology

With unique expertise in aptamer research and development, Base Pair Biotechnologies consistently advances the efficiency of our service, while dramatically reducing costs. Our scientists invented an exclusive multiplex technology that screens up to 30 targets at once. The benefits pass to you:

  • Increased chance of success. It’s not always possible to isolate an aptamer for every target. We cover your bases by helping to pinpoint multiple candidates and screening them all in tandem.
  • Lower costs, greater efficiency. Find multiple aptamers for your projects, or find the best target for just one. Our technology allows you to multiply your discovery options without doubling up the costs.
  • Quicker turn-around. We’re a nimble team and this technology boosts that further. We respond quickly to your project, delivering multiple targets in less time than it takes our competitors to develop one.

Your Aptamer Discovery Partner

Welcome to the world of aptamer discovery, where short strands of DNA or RNA are chosen for a higher purpose. It’s our mission to make aptamers more accessible, through collaboration and a business model that understands and adapts to your needs. We even invented a multiplex technology that streamlines the discovery process. Base Pair delivers tangible benefits to your team, with greater efficiency and greater selection:

  • Low Entry Costs
  • Progressive Ownership
  • Endless Scalability
  • Total, Ongoing Support

Progressive Ownership

We don’t believe in charging large up-front discovery costs. Our goal is to get aptamers in your hands. Instead, we establish multiple checkpoints that minimize your risk. It allows you to evaluate your options as the science progresses. Key decisions, such as whether to commercialize your aptamer sequence, can be made when the time is right. Once the results are in, you choose to:

  • Purchase the aptamer materials and validation data
  • License your custom sequence for publication or further research
  • Take full ownership of the intellectual property for commercialization purposes

There’s one more very important feature of our progressive ownership model. By minimizing your initial discovery costs, we’re taking a share of the risk. It’s a guarantee that if we don’t think your target is a good candidate for your application, we’ll let you know upfront. We’re a resource as well as a partner for custom aptamer discovery.

Progressive Ownership Process



Researcher

University of Parma, Italy

“Base Pair Biotechnologies provided us a tailored solution for our aptamer needs in a fast, efficient and professional manner."